Proteasome inhibition reprograms chromatin landscape in breast cancer

No abstract is available for this paper.

• Publication year

  2023

• Venue

  bioRxiv

• Publication date

  2023-10-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/2023.10.13.562284PMID 37904968PMCID PMC10614768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ERα-associated translocations underlie oncogene amplifications in breast cancer

  2023cited by this paper
• Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters

  2023cited by this paper
• An abundance of free regulatory (19S) proteasome particles regulates neuronal synapses

  2023cited by this paper
• RNA Polymerase II, the BAF remodeler and transcription factors synergize to evict nucleosomes

  2023cited by this paper
• Oncogenic lncRNAs alter epigenetic memory at a fragile chromosomal site in human cancer cells

  2022cited by this paper
• Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 Stabilization and Chromatin Condensation

  2022cited by this paper
• DAXX adds a de novo H3.3K9me3 deposition pathway to the histone chaperone network

  2022cited by this paper
• BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia

  2022cited by this paper
• Histone post-translational modifications — cause and consequence of genome function

  2022cited by this paper
• BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer

  2022cited by this paper
• Regulatory genomic circuitry of human disease loci by integrative epigenomics

  2021influential reference
• Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

  2021cited by this paper
• The language of chromatin modification in human cancers

  2021cited by this paper
• Histone degradation by the proteasome regulates chromatin and cellular plasticity

  2021cited by this paper
• Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance

  2021cited by this paper
• SPT5 stabilization of promoter-proximal RNA polymerase II.

  2021cited by this paper
• clusterProfiler 4.0: A universal enrichment tool for interpreting omics data

  2021influential reference
• Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation

  2020cited by this paper
• Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer

  2020cited by this paper
• Stress- and ubiquitylation-dependent phase separation of the proteasome

  2020cited by this paper
• Cell cycle–dependent localization of the proteasome to chromatin

  2020cited by this paper
• ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation

  2020cited by this paper
• Clinical implications of chromatin accessibility in human cancers

  2020cited by this paper
• Partitioning of cancer therapeutics in nuclear condensates

  2020cited by this paper
• GTRD: an integrated view of transcription regulation

  2020cited by this paper
• Sequence Analysis

  2020influential reference
• Genome-wide RNA pol II initiation and pausing in neural progenitors of the rat

  2019influential reference
• Estrogen receptor signaling is reprogrammed during breast tumorigenesis

  2019cited by this paper
• MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation

  2019cited by this paper
• Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity

  2019cited by this paper
• The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer

  2019cited by this paper
• Hippocampal Subregions Express Distinct Dendritic Transcriptomes that Reveal Differences in Mitochondrial Function in CA2.

  2019influential reference
• microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1

  2019cited by this paper
• The chromatin accessibility landscape of primary human cancers

  2018cited by this paper
• Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.

  2018cited by this paper
• Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes

  2017cited by this paper
• Positioning of proteasome inhibitors in therapy of solid malignancies

  2017cited by this paper
• Proteasome inhibitors in cancer therapy

  2017cited by this paper
• Transcriptional Addiction in Cancer.

  2017cited by this paper
• Inhibition of the Proteasome β2 Site Sensitizes Triple-Negative Breast Cancer Cells to β5 Inhibitors and Suppresses Nrf1 Activation.

  2017cited by this paper
• Histone chaperone networks shaping chromatin function

  2017cited by this paper
• GATA3-dependent cellular reprogramming requires activation-domain dependent recruitment of a chromatin remodeler

  2016influential reference
• Complex heatmaps reveal patterns and correlations in multidimensional genomic data

  2016cited by this paper
• Histone H3 globular domain acetylation identifies a new class of enhancers

  2016cited by this paper
• ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide

  2015influential reference
• Bidirectional Transcription Arises from Two Distinct Hubs of Transcription Factor Binding and Active Chromatin.

  2015cited by this paper
• Functions of the Proteasome on Chromatin

  2014cited by this paper
• Regulation of histone modifying enzymes by the ubiquitin-proteasome system.

  2014cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• The 26S Proteasome and Initiation of Gene Transcription

  2014cited by this paper
• Transcriptional enhancers: from properties to genome-wide predictions

  2014cited by this paper
• Ubiquitylation and degradation of elongating RNA polymerase II: the last resort.

  2013cited by this paper
• Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells.

  2013cited by this paper
• Super-enhancers in the control of cell identity and disease.

  2013cited by this paper
• Divergent transcription is associated with promoters of transcriptional regulators

  2013cited by this paper
• Selective inhibition of tumor oncogenes by disruption of super-enhancers.

  2013cited by this paper
• Master transcription factors and mediator establish super-enhancers at key cell identity genes.

  2013cited by this paper
• Modification of enhancer chromatin: what, how, and why?

  2013cited by this paper
• Comprehensive molecular portraits of human breast tumours

  2013cited by this paper
• STAR: ultrafast universal RNA-seq aligner

  2013cited by this paper
• Proteasomal AAA-ATPases: structure and function.

  2012cited by this paper
• The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.

  2011cited by this paper
• The proteasome and its regulatory roles in gene expression.

  2011cited by this paper
• Cutadapt removes adapter sequences from high-throughput sequencing reads

  2011influential reference
• Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation.

  2010cited by this paper
• Global Analysis of Short RNAs Reveals Widespread Promoter-Proximal Stalling and Arrest of Pol II in Drosophila

  2010cited by this paper
• A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer

  2009cited by this paper
• Distinct ubiquitin ligases act sequentially for RNA polymerase II polyubiquitylation

  2009cited by this paper
• Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

  2009influential reference
• Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters

  2008cited by this paper
• Divergent Transcription from Active Promoters

  2008cited by this paper
• Regulation of Acetylation at the Major Histocompatibility Complex Class II Proximal Promoter by the 19S Proteasomal ATPase Sug1

  2008cited by this paper
• Proteasome Activity Modulates Chromatin Modifications and RNA Polymerase II Phosphorylation To Enhance Glucocorticoid Receptor-Mediated Transcription

  2007cited by this paper
• The role of chromatin during transcription.

  2007cited by this paper
• High-resolution profiling of histone methylations in the human genome.

  2007cited by this paper
• The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells.

  2006cited by this paper
• Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.

  2005cited by this paper
• Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription.

  2005cited by this paper
• A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors.

  2004cited by this paper
• Rapid Glucocorticoid Receptor Exchange at a Promoter Is Coupled to Transcription and Regulated by Chaperones and Proteasomes

  2004cited by this paper
• Estrogen Receptor-Dependent Proteasomal Degradation of the Glucocorticoid Receptor Is Coupled to an Increase in Mdm2 Protein Expression

  2003cited by this paper
• Inhibition of Proteasome Activity Induces Concerted Expression of Proteasome Genes and de Novo Formation of Mammalian Proteasomes*

  2003cited by this paper
• An abundance of bidirectional promoters in the human genome.

  2003cited by this paper
• Genome Amplification of Chromosome 20 in Breast Cancer

  2003cited by this paper
• BIOINFORMATICS APPLICATIONS NOTE

  2001cited by this paper
• Proteasome inhibitors: from research tools to drug candidates.

  2001cited by this paper
• Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis.

  2000cited by this paper
• Proteasome-dependent degradation of the human estrogen receptor.

  1999cited by this paper
• Estrogen receptors and cell proliferation in breast cancer.

  1997cited by this paper
• Crystal structure of the nucleosome core particle at 2.8 Å resolution

  1997cited by this paper
• The human histone gene cluster at the D6S105 locus

  1997cited by this paper
• A highly conserved ATPase protein as a mediator between acidic activation domains and the TATA-binding protein

  1995cited by this paper
• A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II.

  1994cited by this paper
• The ubiquitin-proteasome proteolytic pathway.

  1994cited by this paper
• Chromatin structure: a repeating unit of histones and DNA.

  1974cited by this paper
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper

• H3K27me3 chromatin heterogeneity reveals variable cell responses to estrogen and endocrine treatment

  2025cites this paper